AG003P0N

135046-48-9 | Clopidogrel bisulfate

AG003P0N

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	135046-48-9
Catalog Number	AG003P0N(AGN-PC-0PKHIW)
Chemical Name	Clopidogrel bisulfate
IUPAC Name	methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid
InChI	InChI=1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)/t15-;/m0./s1
InChI Key	FDEODCTUSIWGLK-RSAXXLAASA-N
MDL Number	MFCD05865229
Molecular Formula	C16H18ClNO6S2
Molecular Weight	419.9002
NSC Number	758613
SMILES	S(=O)(=O)(O)O.ClC1=C(C=CC=C1)C(C(=O)OC)N1CC2=C(CC1)SC=C2
UNII	08I79HTP27
Synonyms	clopidogrel, clopidogrel besilate, clopidogrel besylate, clopidogrel bisulfate, clopidogrel hydrochloride, Clopidogrel Mepha, clopidogrel napadisilate, clopidogrel Sandoz, clopidogrel, (+)(S)-isomer, clopidogrel-Mepha, Iscover, PCR 4099, PCR-4099, Plavix, SC 25989C, SC 25990C, SR 25989, Clopidogrel bisulfate, 120202-66-6, Clopidogrel hydrogen sulfate, Iscover, Plavix, 135046-48-9, Clopidogrel bisulphate, Clopidogrel hemisulfate, (S)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate, Myogrel, Clopidogrel sulphate, clopidogrel hydrogen sulphate, Clopidogrel (hydrogen sulfate), CLOPIDOGREL SULFATE, UNII-08I79HTP27, Clopidogrel (Plavix), SR 25990C, Clopidogrel Bisulfate [USAN], (S)-(+)-Clopidogrel Sulfate, SR-25990C, 08I79HTP27, MFCD05865229, PM-103, (S)-(+)-Clopidogrel hydrogen sulfate, SR-25990, Clopidogrel hydrogensulfate, Plavix (TN), (S)-( )-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno(3,2-c)pyrid-5-yl)acetate bisulfate, DSSTox_CID_26024, DSSTox_RID_81297, Methyl alphaS-(2-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate sulfate (1:1), DSSTox_GSID_46024, 144077-07-6, Clopidogrel bisulfate (USAN), Plavitor, Osvix, CHEBI:3759, CHEMBL1083385, methyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate, Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate, sulfate (1:1), methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate; sulfuric acid, methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate; sulfuric acid, Thieno(3,2-c)pyridine-5(4H)-acetic acid, alpha-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (alphaS)-, sulfate (1:1), Thieno(3,2-c)pyridine-5(4H)-acetic acid, alpha-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (S)-, sulfate (1:1), (S)-(+)-Clopidogrel hydrogensulfate, 98%, CAS-135046-48-9, MFCD00876395, Clopidogrel bisulfate [USAN:USP], Isocover (TN), methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid, Clopidogrel-bisulfate, Iscover;Myogrel;Plavix, AC1L3GZZ, Clopidogrelhydrogensulphate, clopidogrel; sulfuric acid, NCGC00159321-02, (+)-clopidogrel bisulfate, (+) Clopidogrel Bisulfate, C16H18ClNO6S2, Clopidogrel sulfate (JP17), SCHEMBL33556, Clopidogrel hydrogen sulphate, SPECTRUM1503710, MDCO-157, DTXSID4046024, CTK8B5120, (+)-clopidogrel hydrogen sulfate, FDEODCTUSIWGLK-RSAXXLAASA-N, Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate, HMS1922G16, HMS2093I13, Pharmakon1600-01503710, Methyl (S)-(+)-2-(2-Chlorophenyl)-2-[6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl]acetate Sulfate, (+/-) Clopidogrel hydrogen sulfate, (+/-)-Clopidogrel hydrogen sulfate, Clopidogrel sulfate tablets (JP17), Tox21_111570, ANW-47676, CCG-39568, FC1269, NSC758613, s1415, AKOS015900408, Clopidogrel Bisulphate USP (Form II), Tox21_111570_1, AC-2135, CS-1882, DV-7314, KS-1045, MCULE-2362021814, NSC-758613, RTR-004741, S65C842, NCGC00163329-03, 111GE004, AN-10793, AN-14258, BR-58351, HY-17459, SC-08806, Thieno(3,2-c)pyridine-5(4H)-acetic acid, 6,7-dihydro-alpha-(2-chlorophenyl)-, methyl ester, (S)-, sulfate, AB0012679, AB2000095, LS-152396, LS-172438, TL8000537, FT-0603200, SW219457-1, A19581, D00769, Y-9563, SR-05000002068, J-006637, SR-05000002068-1, (S)-(+)-Clopidogrel hydrogensulfate, >=98% (HPLC), Z1550648767, Clopidogrel bisulfate, United States Pharmacopeia (USP) Reference Standard, Clopidogrel hydrogen sulfate, European Pharmacopoeia (EP) Reference Standard, Clopidogrel Bisulfate, Pharmaceutical Secondary Standard; Certified Reference Material, Clopidogrel for system suitability, European Pharmacopoeia (EP) Reference Standard, (S)-(+)-Methyl 2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)-2-(2-chlorophenyl)acetate hydrogen sulfate, (S)-(2-Chloro-phenyl)-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)-acetic acid methyl ester sulfuric acid salt, (S)-METHYL-(2-CHLORO-PHENYL)-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETATE H2SO4, Thieno[3,2-c]pyridine-5(4H)-acetic acid,a-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (aS)-, sulfate (1:1), clopidogrel, Lovalip, Thrombo, Zyllt, Clopidogrel BMS, Clopidogrel HCS, Clopidogrel Acino, Clopidogrel Hexal, (S)-Clopidogrel, Clopidogrel Winthrop, Clopidogrel 1A Pharma, (+)-(S)-Clopidogrel, Clopidogrel [BAN:INN], Clopidogrel [INN:BAN], (+/-)-Clopidogrel bisulfate, Clopidogrel ratiopharm GmbH, C16H16ClNO2S.H2O4S, UNII-A74586SNO7, HSDB 7430, C16-H16-Cl-N-O2-S, SR25990C, CID115366, Clopidogrel Teva (hydrogen sulphate), ACN-040052, CS-O-07679, 113665-84-2, SR 25990, C16-H16-Cl-N-O2-S.H2-O4-S, C2556, A10233, (S)-( )-Clopidogrel sulfate, 98% - 1G 1g, R 130964, (2-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5-(4h)-acetic acid methyl ester sulfate, methyl (+)-(S)alpha-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, (alpha S)-alpha-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester, 75330-75-5, methyl (s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4h)-acetate hydrogen sulfate,

Complexity	463
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	419.026g/mol
Formal Charge	0
Heavy Atom Count	26
Hydrogen Bond Acceptor Count	8
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	419.891g/mol
Monoisotopic Mass	419.026g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	141A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	\N
Hazard statements	H302-H315-H319-H335
Packing Group	\N
Precautionary statements	P261-P305+P351+P338
UN Code	\N

Certificate of Analysis

Lot Number